DE69117067D1 - Verbesserung bei festphasenbindungs-analysenverfahren - Google Patents

Verbesserung bei festphasenbindungs-analysenverfahren

Info

Publication number
DE69117067D1
DE69117067D1 DE69117067T DE69117067T DE69117067D1 DE 69117067 D1 DE69117067 D1 DE 69117067D1 DE 69117067 T DE69117067 T DE 69117067T DE 69117067 T DE69117067 T DE 69117067T DE 69117067 D1 DE69117067 D1 DE 69117067D1
Authority
DE
Germany
Prior art keywords
improvement
analyzing method
solid binding
binding
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69117067T
Other languages
English (en)
Other versions
DE69117067T2 (de
Inventor
Stefan Loefas
Inger Roennberg
Katarina Lagerstroem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biacore AB
Original Assignee
Pharmacia Biosensor AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Biosensor AB filed Critical Pharmacia Biosensor AB
Publication of DE69117067D1 publication Critical patent/DE69117067D1/de
Application granted granted Critical
Publication of DE69117067T2 publication Critical patent/DE69117067T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
DE69117067T 1990-10-01 1991-09-26 Verbesserung bei festphasenbindungs-analysenverfahren Expired - Fee Related DE69117067T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003122A SE501013C2 (sv) 1990-10-01 1990-10-01 Förfarande för förbättring av analys med bindning till fast fas
PCT/SE1991/000649 WO1992006380A1 (en) 1990-10-01 1991-09-26 Improvement in solid phase binding assay

Publications (2)

Publication Number Publication Date
DE69117067D1 true DE69117067D1 (de) 1996-03-21
DE69117067T2 DE69117067T2 (de) 1996-10-02

Family

ID=20380510

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69117067T Expired - Fee Related DE69117067T2 (de) 1990-10-01 1991-09-26 Verbesserung bei festphasenbindungs-analysenverfahren

Country Status (6)

Country Link
US (1) US5716854A (de)
EP (1) EP0553229B1 (de)
JP (1) JPH06501555A (de)
DE (1) DE69117067T2 (de)
SE (1) SE501013C2 (de)
WO (1) WO1992006380A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569620B1 (en) 1990-06-11 2003-05-27 Somalogic, Inc. Method for the automated generation of nucleic acid ligands
US5861254A (en) * 1997-01-31 1999-01-19 Nexstar Pharmaceuticals, Inc. Flow cell SELEX
US6716580B2 (en) 1990-06-11 2004-04-06 Somalogic, Inc. Method for the automated generation of nucleic acid ligands
US5576220A (en) * 1993-02-19 1996-11-19 Arris Pharmaceutical Corporation Thin film HPMP matrix systems and methods for constructing and displaying ligands
SE9303272D0 (sv) * 1993-10-07 1993-10-07 Pharmacia Biosensor Ab Improvement in immunoassays
SE9403245D0 (sv) * 1994-09-26 1994-09-26 Pharmacia Biosensor Ab Improvements relating to bilayer lipid membranes
US20030211507A1 (en) * 1996-03-29 2003-11-13 Anson Hatch Microscale diffusion immunoassay in hydrogels
FR2781885B1 (fr) * 1998-07-28 2000-09-08 Jacques Toledano Dispositif et procede electrostatiques de detection immunologique fine
ATE295541T1 (de) 1999-06-18 2005-05-15 Biacore Ab Verfahren und vorrichtung zur untersuchung von wirksstoffskandidaten und zur bestimmung ihrer pharmakokinetischen parametern
JP4684507B2 (ja) 1999-07-05 2011-05-18 ノバルティス アーゲー センサープラットホームを使用する方法
US6771376B2 (en) * 1999-07-05 2004-08-03 Novartis Ag Sensor platform, apparatus incorporating the platform, and process using the platform
US6579726B1 (en) 1999-07-30 2003-06-17 Surromed, Inc. Instruments, methods and reagents for surface plasmon resonance
US7167615B1 (en) 1999-11-05 2007-01-23 Board Of Regents, The University Of Texas System Resonant waveguide-grating filters and sensors and methods for making and using same
WO2002079761A1 (en) * 2001-04-02 2002-10-10 Prolinx Incorporated Systems and apparatus for the analysis of molecular interactions
US7179659B2 (en) * 2001-04-02 2007-02-20 Agilent Technologies, Inc. Sensor surfaces for detecting analytes and methods of use
EP1343010A1 (de) * 2002-03-04 2003-09-10 Glaucus Proteomics B.V. Matrix zur Immobilisierung von biologischen Substanzen, sowie Verfahren zur Herstellung und Verwending derartige Matrixen
WO2003075012A1 (en) * 2002-03-04 2003-09-12 Steinberg Holding B.V. Matrix for coupling of a biological molecule, method for producing and use of said matrix
US7141369B2 (en) * 2002-04-25 2006-11-28 Semibio Technology, Inc. Measuring cellular metabolism of immobilized cells
TWI316603B (en) * 2002-12-17 2009-11-01 Ind Tech Res Inst Method for immunoassays based on infrared reflection absorption spectroscopy
EP1730531B1 (de) * 2004-03-24 2014-01-15 Technion Research and Development Foundation, Limited Elektrode
US8354066B2 (en) * 2004-03-24 2013-01-15 Technion Research & Development Foundation Ltd. Artificial receptors
US7749445B2 (en) * 2005-05-02 2010-07-06 Bioscale, Inc. Method and apparatus for analyzing bioprocess fluids
US7648844B2 (en) * 2005-05-02 2010-01-19 Bioscale, Inc. Method and apparatus for detection of analyte using an acoustic device
US7300631B2 (en) 2005-05-02 2007-11-27 Bioscale, Inc. Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
US7611908B2 (en) * 2005-05-02 2009-11-03 Bioscale, Inc. Method and apparatus for therapeutic drug monitoring using an acoustic device
KR100899811B1 (ko) * 2006-12-05 2009-05-27 한국전자통신연구원 유기물 고굴절 재료를 포함하는 공진 반사광 필터와 이를구비한 광 바이오센서
EP2336314A1 (de) 2007-07-17 2011-06-22 Somalogic, Inc. Verbessertes Selex und Photoselex
WO2009033056A1 (en) * 2007-09-06 2009-03-12 Bioscale, Inc. Reusable detection surfaces and methods of using same
GB201008682D0 (en) * 2010-05-25 2010-07-07 Vib Vzw Epitope tag for affinity based applications
US11047859B2 (en) 2014-06-24 2021-06-29 Cytiva Sweden Ab Normalization of mass transport properties on optical sensor surfaces
JP6665485B2 (ja) * 2015-10-29 2020-03-13 東ソー株式会社 抗体依存性細胞傷害活性に基づく抗体の分析方法
JP7203034B2 (ja) * 2017-10-02 2023-01-12 大塚製薬株式会社 アナライトの検出方法
IT201900011055A1 (it) * 2019-07-05 2021-01-05 Broi Ugo Da Dispositivo diagnostico portatile e relativo metodo diagnostico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287300A (en) * 1979-07-26 1981-09-01 Syva Company Charge effects in enzyme immunoassays
WO1983002954A1 (en) * 1982-02-23 1983-09-01 Ventrex Lab Inc Multipurpose supports for immunological and biological use
EP0230768B1 (de) * 1985-12-20 1992-03-18 Syntex (U.S.A.) Inc. Teilchentrennungsverfahren
US4829009A (en) * 1986-02-21 1989-05-09 The Regents Of The University Of California Noise controlled immunoassays
US5459080A (en) * 1988-01-29 1995-10-17 Abbott Laboratories Ion-capture assays using a specific binding member conjugated to carboxymethylamylose
US5459078A (en) * 1988-01-29 1995-10-17 Abbott Laboratories Methods and reagents for performing ion-capture digoxin assays
US5244630A (en) * 1988-04-22 1993-09-14 Abbott Laboratories Device for performing solid-phase diagnostic assay
SE462454B (sv) 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
SE8804074D0 (sv) * 1988-11-10 1988-11-10 Pharmacia Ab Sensorenhet och dess anvaendning i biosensorsystem
CA1341592C (en) * 1989-07-07 2009-04-14 Abbott Laboratories Ion capture reagents and methods for performing binding assays

Also Published As

Publication number Publication date
EP0553229A1 (de) 1993-08-04
SE9003122L (sv) 1992-04-02
SE9003122D0 (sv) 1990-10-01
US5716854A (en) 1998-02-10
EP0553229B1 (de) 1996-02-07
WO1992006380A1 (en) 1992-04-16
DE69117067T2 (de) 1996-10-02
JPH06501555A (ja) 1994-02-17
SE501013C2 (sv) 1994-10-17

Similar Documents

Publication Publication Date Title
DE69117067T2 (de) Verbesserung bei festphasenbindungs-analysenverfahren
DE69030988D1 (de) Stickstoffenthaltender cermet
DE69524273T2 (de) Automatisierte Analysator
DE69410636T2 (de) Bindungsbestimmung
MX174001B (es) Composiciones cementicias y metodo
DE69208789D1 (de) Sortierverfahren
NO175965C (no) Skibinding
DE69433888D1 (de) Proben-entnahme
BR9104887A (pt) Fecho de ligadura
DE69104695T2 (de) Explosionsbindeverfahren.
ID870B (id) Metode pembuatan ritsleting
IT9020623A0 (it) procedimento
ATA36890A (de) Skibindung
DE9405224U1 (de) Automatisches Analysegerät
FR2647842B1 (fr) Perfectionnement aux espagnolettes
ATE134041T1 (de) Verbesserung bei festphasenbindungs- analysenverfahren
DE69024422T2 (de) Komprimierungsverfahren
GB9111893D0 (en) Analytical method
EP0469519A3 (en) Method for analyzing glycoalbumin
KR910009175U (ko) 항타공법용 파일
ITRA940014A0 (it) Simulatore sciistico propedeutico
DE29500356U1 (de) Probennehmer
DE9421488U1 (de) Schablone in Kammform
BR7000391U (pt) Disposicao construtiva em aglutinador
SE9000782D0 (sv) Affischeringsmetod

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee